AEON Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	89	268	347	335	-
Market Cap Growth	-22.84%	-22.84%	3.50%	-	-
Enterprise Value	84	262	469	417	0
PE Ratio	-	-0.83	-6.60	-6.02	-
PB Ratio	-1.75	-1.75	-1.21	-1.43	-
P/FCF Ratio	-10.26	-10.26	-9.66	-11.71	-
P/OCF Ratio	-10.26	-10.26	-9.74	-11.78	-
EV/EBITDA Ratio	-0.81	-0.81	-8.93	-7.49	-10.75
EV/EBIT Ratio	-0.81	-0.81	-8.91	-7.49	-10.75
EV/FCF Ratio	-10.06	-10.06	-13.05	-14.57	-
Debt / Equity Ratio	-	-	-0.46	-0.37	1.80
Debt / EBITDA Ratio	-	-	-2.51	-1.56	-10.75
Debt / FCF Ratio	-	-	-3.66	-3.04	-
Quick Ratio	0.40	0.40	0.12	0.25	0
Current Ratio	0.48	0.48	0.12	0.25	0
Return on Equity (ROE)	147.10%	147.10%	64.60%	75.70%	-
Return on Assets (ROA)	-3676.50%	-3676.50%	-25.00%	-26.50%	-
Return on Capital (ROIC)	242.54%	242.54%	31.05%	44.47%	-5.98%
Earnings Yield	-364.78%	-121.08%	-15.16%	-16.61%	-
FCF Yield	-29.37%	-9.75%	-10.35%	-8.54%	-
Buyback Yield / Dilution	73.24%	73.24%	-9.98%	-2004.21%	-
Total Shareholder Return	73.24%	73.24%	-9.98%	-2004.21%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).